首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1533609

生物標記市場規模、佔有率、成長分析，按產品/服務、按類型、按技術、按應用、按地區 - 產業預測，2024-2031

Biomarkers Market Size, Share, Growth Analysis, By Product & Service, By Type, By Technology, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年08月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球生物標記市場規模將為669.7億美元，高於2023年的758.8億美元，在預測期（2024-2031）至2031年期間複合年成長率為13.3%，預計將達到2060.4億美元。

該市場受到多種因素的推動，包括由於癌症發病率上升而導致伴同性診斷的重要性日益增加、生物標記研究資金的增加以及從正在進行的研究中獲得的重要見解。例如，2023年10月，波士頓大學研究人員獲得了美國國立衛生研究院460萬美元的津貼，用於開發肺癌的新生物標記。研究在發現多種疾病的有效治療方法方面發揮重要作用，包括癌症、心血管疾病、免疫失調和神經系統疾病。它也有助於早期發現和闡明這些疾病的預防方法。隨著公共和私人資金的增加，該領域的投資巨大。例如，2022 年 3 月，Quanterix Corp. 宣布阿茲海默症藥物發現基金會提供資金，以加速阿茲海默症診斷血漿檢驗的開發。預計未來幾年生物標記在感染疾病診斷中的作用也將顯著擴大。根據《微生物學前沿》報導，已經確定了多種疾病的潛在基於 MicroRNA 的生物標記物，包括鼻病毒、流感、結核病、愛滋病毒、瘧疾、伊波拉出血熱和亨德拉病毒。這些基於微型RNA的生物標記旨在促進感染的早期檢測。此外，生物標記也用於神經系統疾病的治療，以測量分子並監測大腦的狀態。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

F. Hoffmann-La Roche AG（Switzerland）
Thermo Fisher Scientific Inc.（United States）
Agilent Technologies, Inc.（United States）
QIAGEN NV（Netherlands）
Bio-Rad Laboratories, Inc.（United States）
Merck & Co., Inc.（United States）
PerkinElmer, Inc.（United States）
Illumina, Inc.（United States）
BD（Becton, Dickinson and Company）（United States）
Myriad Genetics, Inc.（United States）
Siemens Healthineers AG（Germany）
Danaher Corporation（United States）
Biomerieux SA（France）
Waters Corporation（United States）
Abbott Laboratories（United States）
Sysmex Corporation（Japan）
Bio-Techne Corporation（United States）
Charles River Laboratories International, Inc.（United States）
Eurofins Scientific SE（Luxembourg）
Pacific Biomarkers（United States）

簡介目錄

Product Code: SQMIG35A2509

Global Biomarkers Market size was valued at USD 66.97 Billion in 2022 and is expected to rise from USD 75.88 Billion in 2023 to reach a value of USD 206.04 Billion by 2031, at a CAGR of 13.3% over the forecast period (2024-2031).

The market is expected to experience growth due to several factors, including the increasing significance of companion diagnostics driven by rising cancer rates, increased funding for biomarker research, and significant findings from ongoing studies. For example, in October 2023, researchers from Boston University received a $4.6 million grant from the National Institutes of Health to develop new biomarkers for lung cancer. Research plays a crucial role in discovering effective treatments for a variety of conditions such as cancer, cardiovascular, immunological, and neurological diseases. It also helps in understanding early detection and preventive measures for these diseases. Investment in this field has been notable, with increased public and private funding. For instance, in March 2022, Quanterix Corp. announced that the Alzheimer's Drug Discovery Foundation had provided funding to accelerate the development of a diagnostic plasma test for Alzheimer's disease. The role of biomarkers in diagnosing infectious diseases is also expected to expand significantly in the coming years. According to *Frontiers in Microbiology*, potential MicroRNA-based biomarkers have been identified for various illnesses, including rhinoviruses, influenza, tuberculosis, HIV, malaria, Ebola, and Hendra virus. These MicroRNA-based biomarkers are designed to facilitate the early detection of infections. Additionally, biomarkers are utilized in managing neurological diseases to measure molecules and monitor brain conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomarkers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomarkers Market Segmental Analysis

The biomarkers market is segmented based on Product & Service, Type, Research Area, Technology, Disease Indication, Application, End User, and Region. Based on Product & Service, the market is segmented into Consumables (Assay Kits, Reagents & Chemicals, Columns & Filters), Services, and Software. Based on Type, the market is segmented into Safety Biomarkers, Efficacy Biomarkers (Predictive Biomarkers, Surrogate Biomarkers, Pharmacodynamic Biomarkers, Prognostic Biomarkers), Validation Biomarkers. Based on Research Area, the market is segmented into Genomics, Proteomics, Metabolomics, and Other Research Areas. Based on Technology, the market is segmented into Immunoassays (ELISA, Protein Microarrays, Western Blot), NGS, PCR, Mass Spectrometry, Chromatography, and Other Technologies. Based on Disease Indication, the market is segmented into Cancer, Infectious Diseases, Immunological Disorders, Neurological Disorders, Cardiovascular Disorders, and Other Disease Indications. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicine, Clinical Research, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Other End Users. Based on Region, the biomarkers market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa.

Drivers of the Global Biomarkers Market

The increasing prevalence of chronic diseases has heightened the need for advanced early detection equipment. Biomarkers play a vital role by enabling the identification and monitoring of diseases at a molecular level. Advances in omics platforms, including genomics and proteomics, are driving the development of new biomarkers, thereby improving diagnostic capabilities. Furthermore, the growing emphasis on personalized medicine and precise therapeutic strategies is boosting the demand for biomarkers that can tailor treatments to individual patient profiles.

Restraints in the Global Biomarkers Market

Several challenges have made biomarker validation and standardization difficult. Variability in biomarker effects and issues preventing their integration into clinical practice are key obstacles. The slow implementation of biomarkers is partly due to policy concerns and the need for more rigorous validation methods. Additionally, there are ethical and regulatory issues related to the privacy and safety of patient information in biomarker-based diagnostics. High development costs, particularly in the discovery of new biomarkers, further restrict their widespread use.

Market Trends of the Global Biomarkers Market

Liquid biopsy is an innovative, minimally invasive diagnostic technique that detects biomarkers in a patient's blood or other fluids. Gaining increasing attention in the biomarkers market, liquid biopsy facilitates early cancer detection and disease diagnosis, and can also assess treatment effectiveness. Several companies are actively working on commercializing liquid biopsy tests, and this market is expected to grow rapidly in the coming years.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Supply Chain Analysis
Ecosystem of the Market
Start-up Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Biomarkers Market by Product & Service

Market Overview
Consumables
- Assay Kits
- Reagents & Chemicals
- Columns & Filters
Services
Software

Biomarkers Market by Type

Market Overview
Safety Biomarkers
Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostic Biomarkers
Validation Biomarkers

Biomarkers Market by Research Area

Market Overview
Genomics
Proteomics
Metabolomics
Other Research Areas

Biomarkers Market by Technology

Market Overview
Immunoassays
- ELISA
- Protein Microarrays
- Western Blot
NGS
PCR
Mass Spectrometry
Chromatography
Other Technologies

Biomarkers Market by Disease Indication

Market Overview
Cancer
Infectious Diseases
Immunological Disorders
Neurological Disorders
Cardiovascular Disorders
Other Disease Indications

Biomarkers Market by Application

Market Overview
Clinical Diagnostics
Drug Discovery & Development
Personalized Medicine
Clinical Research
Other Applications

Biomarkers Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Academic & Research Institutes
Other End Users

Biomarkers Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biomarkers (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments